1. Synthesis and antiproliferative activity of new bioconjugates of Salinomycin with amino acid esters
   Michał Antoszczak et al, 2015, Bioorganic & Medicinal Chemistry Letters CrossRef
2. Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers
   Vivek Kaushik et al, 2018, Cancers CrossRef
3. Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions
   Maximilian Boesch et al, 2016, The Oncologist CrossRef
4. Studying of Inhibitory Effect of Salinomycin on Glioblastoma U87 Cells
   健英 乔, 2021, Hans Journal of Biomedicine CrossRef
5. Identification of a panel of genes as a prognostic biomarker for glioblastoma
   Fengfei Wang et al, 2018, EBioMedicine CrossRef
6. Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore
   Yi Chieh Lim et al, 2019, Neuro-Oncology CrossRef
7. Recent Advancements in Liposome-Targeting Strategies for the Treatment of Gliomas: A Systematic Review
   Jie Li et al, 2020, ACS Applied Bio Materials CrossRef
8. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment
   Lakshmi Pallavi Ganipineni et al, 2018, Journal of Controlled Release CrossRef
9. Combination of Salinomycin and AZD3463 Reveals Synergistic Effect on Reducing the Viability of T98G Glioblastoma Cells
   Aycan Asik et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
10. A Yeast Mutant Screen Identifies TORC and Lys63 Polyubiquitination Pathway Genes among Determinants of Sensitivity to the Cancer Stem Cell-Specific Drug Salinomycin
    null Donald Rozario et al, 2021, Journal of Analytical Oncology CrossRef
11. Chemical biology of salinomycin
    Antoine Versini et al, 2018, Tetrahedron CrossRef
12. Salinomycin targets the genome of radioresistant cells in glioblastomas
    Steven L Carroll et al, 2020, Neuro-Oncology CrossRef
13. Borneol-modified docetaxel plus tetrandrine micelles for treatment of drug-resistant brain glioma
    Yang Liu et al, 2024, Drug Development and Industrial Pharmacy CrossRef
14. Effects of D-α-tocopherol polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles on the absorption, pharmacokinetics, and pharmacodynamics of salinomycin sodium
    Jie Li et al, 2019, Anti-Cancer Drugs CrossRef
15. Salinomycin and its derivatives – A new class of multiple-targeted “magic bullets”
    Michał Antoszczak et al, 2019, European Journal of Medicinal Chemistry CrossRef
16. Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
    Liguo Ye et al, 2021, Frontiers in Molecular Neuroscience CrossRef
17. Dual-functional drug liposomes in treatment of resistant cancers
    Li-Min Mu et al, 2017, Advanced Drug Delivery Reviews CrossRef
18. Salinomycin's potential to eliminate glioblastoma stem cells and treat glioblastoma multiforme (Review)
    Justin W. Magrath et al, 2017, International Journal of Oncology CrossRef
19. Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?
    Qian Zhang et al, 2017, Cellular and Molecular Life Sciences CrossRef
20. Induction of G1 Cell Cycle Arrest in Human Glioma Cells by Salinomycin Through Triggering ROS-Mediated DNA Damage In Vitro and In Vivo
    Shi-Jun Zhao et al, 2017, Neurochemical Research CrossRef
21. Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche
    Maximilian Boesch et al, 2016, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
22. A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent
    Michał Antoszczak, 2019, European Journal of Medicinal Chemistry CrossRef
23. Different expression of miR-29b and VEGFA in glioma
    Qiang Liu et al, 2016, Artificial Cells, Nanomedicine, and Biotechnology CrossRef